These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The effect of methylprednisolone treatment on the cardiopulmonary bypass-induced systemic inflammatory response. Bourbon A; Vionnet M; Leprince P; Vaissier E; Copeland J; McDonagh P; Debré P; Gandjbakhch I Eur J Cardiothorac Surg; 2004 Nov; 26(5):932-8. PubMed ID: 15519185 [TBL] [Abstract][Full Text] [Related]
5. Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans. Hill GE; Alonso A; Spurzem JR; Stammers AH; Robbins RA J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1658-62. PubMed ID: 8523876 [TBL] [Abstract][Full Text] [Related]
6. Ginsenosides compound (shen-fu) attenuates gastrointestinal injury and inhibits inflammatory response after cardiopulmonary bypass in patients with congenital heart disease. Xia ZY; Liu XY; Zhan LY; He YH; Luo T; Xia Z J Thorac Cardiovasc Surg; 2005 Aug; 130(2):258-64. PubMed ID: 16077384 [TBL] [Abstract][Full Text] [Related]
7. Does steroid pretreatment increase endotoxin release during clinical cardiopulmonary bypass? Wan S; LeClerc JL; Huynh CH; Schmartz D; DeSmet JM; Yim AP; Vincent JL J Thorac Cardiovasc Surg; 1999 May; 117(5):1004-8. PubMed ID: 10220696 [TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of methylprednisolone in patients on cardiopulmonary bypass. Fecht DC; Magovern GJ; Park SB; Merkow LP; Dixon CM; Dosios T; Pardo M Circ Shock; 1978; 5(4):415-22. PubMed ID: 378452 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-8 production in patients undergoing cardiopulmonary bypass. The influence of pretreatment with methylprednisolone. Jorens PG; De Jongh R; De Backer W; Van Damme J; Van Overveld F; Bossaert L; Walter P; Herman AG; Rampart M Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):890-5. PubMed ID: 8214944 [TBL] [Abstract][Full Text] [Related]
10. Steroid administration in heart and heart-lung transplantation: is the timing adequate? Wan S; DeSmet JM; Antoine M; Goldman M; Vincent JL; LeClerc JL Ann Thorac Surg; 1996 Feb; 61(2):674-8. PubMed ID: 8572786 [TBL] [Abstract][Full Text] [Related]
11. Steroids in heart surgery: a clinical double-blind and randomized study. Toledo-Pereyra LH; Lin CY; Kundler H; Replogle RL Am Surg; 1980 Mar; 46(3):155-60. PubMed ID: 7377659 [TBL] [Abstract][Full Text] [Related]
12. Protective effect of methylprednisolone on the heart during ischemic arrest. Busuttil RW; George WJ; Hewitt RL J Thorac Cardiovasc Surg; 1975 Dec; 70(6):955-65. PubMed ID: 171523 [TBL] [Abstract][Full Text] [Related]
14. Effect of pre-bypass methylprednisolone on post-operative renal function following correction of atrial septal defect under cardiopulmonary bypass. Dhar S; Rahman Z; Hasan K; Hoque MF; Sultana A Mymensingh Med J; 2012 Jan; 21(1):72-9. PubMed ID: 22314458 [TBL] [Abstract][Full Text] [Related]
15. Effects of methylprednisolone on coronary blood flow and myocardial metabolism during cardiopulmonary bypass. Vinas JF; Fewel JG; Grover FL; Richardson JD; Arom KV; Webb GE; Trinkle JK Surgery; 1977 Jun; 81(6):646-52. PubMed ID: 860199 [TBL] [Abstract][Full Text] [Related]
16. Hypotension induced by prostacyclin treatment during cardiopulmonary bypass does not increase the risk of cerebral complications. Arén C; Blomstrand C; Wikkelsö C; Rådegran K J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 1):748-53. PubMed ID: 6208432 [TBL] [Abstract][Full Text] [Related]
17. Pretreatment with hyperbaric oxygen and its effect on neuropsychometric dysfunction and systemic inflammatory response after cardiopulmonary bypass: a prospective randomized double-blind trial. Alex J; Laden G; Cale AR; Bennett S; Flowers K; Madden L; Gardiner E; McCollum PT; Griffin SC J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1623-30. PubMed ID: 16308008 [TBL] [Abstract][Full Text] [Related]
18. Influence of methylprednisolone on levels of neuron-specific enolase in cardiac surgery: a corticosteroid derivative to decrease possible neuronal damage. Demir T; Demir H; Tansel T; Kalko Y; Tireli E; Dayioglu E; Barlas S; Onursal E J Card Surg; 2009; 24(4):397-403. PubMed ID: 19583607 [TBL] [Abstract][Full Text] [Related]
19. Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass. Shernan SK; Fitch JC; Nussmeier NA; Chen JC; Rollins SA; Mojcik CF; Malloy KJ; Todaro TG; Filloon T; Boyce SW; Gangahar DM; Goldberg M; Saidman LJ; Mangano DT; Ann Thorac Surg; 2004 Mar; 77(3):942-9; discussion 949-50. PubMed ID: 14992903 [TBL] [Abstract][Full Text] [Related]
20. A novel protocol of retrograde cerebral perfusion with intermittent pressure augmentation for brain protection. Kitahori K; Takamoto S; Takayama H; Suematsu Y; Ono M; Motomura N; Morota T; Takeuchi K J Thorac Cardiovasc Surg; 2005 Aug; 130(2):363-70. PubMed ID: 16077400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]